Site icon OncologyTube

SLCVL Raez 14 Current Standards Leading Options for First-line Treatment of EGFR Mutation NSCLC

GRACE – Global Resource for Advancing Cancer Education
Published on Feb 14, 2017

Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University joined GRACE to discuss the basics of lung cancer. In this 33rd video for the Spanish lung cancer video library, Dr. Raez discusses current standards and leading options for first-line treatment of EGFR mutation-positive NSCLC.

http://cancerGRACE.org/

Advertisement
Exit mobile version